\(
\def\WIPO{World Intellectual Property Organisation}
\)
格式
| 格式 | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DataCite | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS |
详细记录
Title
Rethinking Pharmaceutical Product Reformulations
Author
项目类型
Journal article
描述
9 pages
摘要
This piece discusses pharmaceutical product reformulations and product hopping strategies, along with the impact that antitrust scrutiny may have on innovation incentives. The main thesis presented is that for the sake of preserving innovation incentives, antitrust analysis should not focus on whether the innovation examined is deemed as an “incremental” one according to antitrust enforcers; on the contrary, the overall economic and strategic context of the product reformulation should play the central role in the case-by-case antitrust analysis.
Supplement Note
Published in : CPI Antitrust Chronicle, 2020
连续资源
Published
[Boston, Massachusetts] : Competition Policy International, 2020.
语言
eng
记录出处